MDR3 and TJP2 deficiency are extremely rare, and only a few studies have reported the outcomes of LT in pediatric patients with MDR3 deficiency [20, 27–31] and TJP2 deficiency [13, 39]. This evidence concerns the gene TJP2 and hyperinsulinemic hypoglycemia, familial, 4.